Mitsubishi Gas Chemical Company (4182) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period of the fiscal year ending March 2026, the Company fell into a net loss attributable to owners of the parent due to lower revenue and profit, in addition to a large impairment loss. Revenue was ¥5,494.6B (-5.8% YoY), Operating Income was ¥378.0B (-16.5% YoY), and Ordinary Income was ¥481.7B (-10.6% YoY). Net income attributable to owners of the parent was ¥-261.6B, a significant deterioration from ¥+356.4B in the same period of the previous year. The primary factors behind the decline in profit were lower sales volumes in the Green Energy & Chemicals Business Segment and the recognition of ¥594.9B in impairment losses, primarily in that segment.

Factors Affecting Performance

【Revenue】Revenue was ¥5,494.6B, representing a 5.8% YoY decline. The Green Energy & Chemicals Business Segment fell sharply to ¥2,093.1B (-11.6% YoY), serving as the main driver of the revenue decline. The Functional Chemicals Business Segment remained relatively stable at ¥3,317.2B (-1.3% YoY). In terms of revenue composition, Functional Chemicals accounted for approximately 60.4%, while Green Energy & Chemicals accounted for approximately 38.1%.

【Profit and Loss】Operating Income was ¥378.0B (-16.5% YoY; Operating Margin 6.9%, compared with 7.8% in the previous year). Although the gross profit margin improved by +0.2pt YoY to 22.4%, the SG&A expense ratio increased to 15.5% from 14.4%, putting pressure on the profit margin. Ordinary Income was ¥481.7B (-10.6% YoY), supported by ¥155.3B in non-operating income, including ¥45.2B in foreign exchange gains and ¥36.8B in dividend income. As a result of recording ¥609.98B in extraordinary losses, including ¥594.9B in impairment losses, of which ¥534.9B related to Green Energy & Chemicals and ¥60.0B to Functional Chemicals, profit before tax was a loss of ¥-72.6B, and net loss attributable to owners of the parent was ¥-261.6B. In addition to lower revenue and profit, the Company incurred a final loss due to a temporary factor—impairment losses.

Segment Analysis

The Functional Chemicals Business Segment maintained high profitability broadly in line with the previous year, with segment profit of ¥386.6B (+0.4% YoY) and a profit margin of 11.7%, making it the core of consolidated earnings. Meanwhile, the Green Energy & Chemicals Business Segment saw segment profit decline to ¥93.9B (-48.9% YoY), with its profit margin falling to 4.5%, and recorded ¥534.9B in impairment losses. Other businesses recorded revenue of ¥84.3B (-19.1% YoY) but improved profit to ¥10.6B (+20.0% YoY), raising the profit margin to 12.5%. The profitability gap between the two core segments—Functional Chemicals at 11.7% versus Green Energy & Chemicals at 4.5%—has widened, clearly indicating a concentration of earnings sources within the portfolio.

Key Financial Indicators

【Profitability】The Operating Margin declined to 6.9% from 7.8% in the previous year. The improvement in the gross profit margin to 22.4% from 22.2% was offset by the increase in the SG&A expense ratio to 15.5% from 14.4%. The net profit margin attributable to owners of the parent was -4.8%, a significant deterioration from +6.1% in the previous year.【Cash Quality】Cash and deposits were ¥695.0B, accounts receivable were ¥1,571.4B, and inventories were ¥1,169.2B, leaving working capital at a high level. The accumulation of inventory and accounts receivable amid declining sales is an issue for capital efficiency.【Investment Efficiency】Annualized ROE was -4.2%, primarily due to the deterioration in the net profit margin, while changes in total asset turnover and financial leverage were limited.【Financial Soundness】The Equity Ratio remained high at 60.2%, compared with 59.7% in the previous year, and current assets of ¥4,655.2B exceeded current liabilities of ¥2,807.6B. The composition of interest-bearing debt, including ¥550.0B in bonds and ¥716.5B in long-term borrowings, remains at a conservative level.

Cash Flow Analysis

As the interim figures from the statement of cash flows are not included in the disclosed data, funding trends are assessed based on changes in the balance sheet. Cash and deposits increased slightly to ¥695.0B from ¥682.5B in the same period of the previous year. Meanwhile, bonds increased by +¥200.0B YoY to ¥550.0B, while commercial paper increased by +¥380.0B YoY to ¥490.0B, indicating a growing reliance on short-term funding. Property, plant and equipment declined by -¥192.7B YoY, largely reflecting the impact of the large impairment loss reducing carrying values. In terms of working capital, accounts receivable of ¥1,571.4B and inventories of ¥1,169.2B remained at high levels. The lack of progress in reducing these balances amid declining sales is an important consideration when assessing cash generation from operating activities.

Earnings Quality

Against Ordinary Income of ¥481.7B, net loss attributable to owners of the parent was ¥-261.6B, resulting in a gap of ¥743.3B. The primary cause of this gap was extraordinary losses of ¥609.98B, of which impairment losses of ¥594.9B accounted for 97.5%, representing a temporary factor. Extraordinary income was limited to ¥55.6B, including ¥35.4B in gains on the sale of fixed assets and ¥12.5B in gains on the sale of investment securities, and was insufficient to offset the impairment losses. Non-operating income of ¥155.3B represented 2.8% of revenue and was not excessive; however, foreign exchange gains of ¥45.2B and dividend income of ¥36.8B are affected by market and investee-company trends, meaning that a portion of profit at the Ordinary Income level was supported by factors outside the core business. Although impairment is a non-recurring accounting treatment, it reflects deteriorating profitability prospects for the affected assets. Accordingly, it would not be appropriate to dismiss the level of net loss simply as a one-time factor.

Earnings Forecast and Guidance

Progress against the revised full-year forecast was 75.3% for revenue (forecast: ¥7,300.0B), 80.4% for Operating Income (forecast: ¥470.0B), and 87.6% for Ordinary Income (forecast: ¥550.0B). Each is either above or broadly in line with the standard 75% progress level. However, against the full-year forecast net loss attributable to owners of the parent of ¥180.0B, the cumulative Q3 loss was already ¥261.6B, exceeding the forecast by ¥81.6B. Without a commensurate profit contribution in Q4, achieving the full-year forecast will be difficult. While progress at the Operating Income and Ordinary Income levels is proceeding smoothly, the final outcome, including extraordinary gains and losses, remains the key focus.

Shareholder Returns

The interim dividend is ¥50.00 per share, and the full-year dividend forecast remains unchanged at ¥100.00 (previous year: ¥45; not directly comparable with the previous-year actual result; no revision to the forecast). If dividends are paid despite the full-year forecast net loss attributable to owners of the parent of ¥180.0B, the Payout Ratio would be negative on a calculated basis, meaning that dividends would not be covered by earnings for the current period. Nevertheless, retained earnings of ¥5,085.9B and net assets of ¥6,704.5B provide a substantial capital base to fund dividends. There was no mention of share repurchases this time, so the assessment is based solely on dividends.

Risk Factors

1. Deterioration in the profitability of the Green Energy & Chemicals Business: Revenue in this segment declined -11.6% YoY, while segment profit declined -48.9% YoY, and the segment recorded ¥534.9B in impairment losses. If weak demand and deteriorating profitability continue, restoring the profitability of assets after impairment will remain a challenge.

2. Declining working capital efficiency: Working capital remains high, with accounts receivable of ¥1,571.4B and inventories of ¥1,169.2B. The accumulation of inventory and accounts receivable amid declining sales could put pressure on capital efficiency.

3. Increased reliance on short-term funding: Commercial paper increased by +¥380.0B YoY to ¥490.0B, while bonds increased by +¥200.0B YoY to ¥550.0B, resulting in somewhat higher sensitivity to changes in interest-rate conditions and credit markets.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

Both the Company's Operating Margin and Net Profit Margin are below the industry median, with the Net Profit Margin showing particularly significant underperformance.

Growth and Capital Efficiency

The Revenue Growth Rate is significantly below the industry median, placing the Company among manufacturers experiencing a decline in revenue.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The Functional Chemicals Business Segment maintained a segment profit margin of 11.7% and remains the core of consolidated earnings, while the Green Energy & Chemicals Business Segment saw its profit margin decline to 4.5% and recorded ¥534.9B in impairment losses. The widening profitability gap between the two segments is a key point regarding the composition of the business portfolio.

2. Progress toward full-year Operating Income and Ordinary Income is above the standard level, but the net loss attributable to owners of the parent has already exceeded the full-year forecast by ¥81.6B. Extraordinary gains and losses and tax effects in Q4 will determine the full-year outcome.

3. Financial soundness is being maintained, as reflected by an Equity Ratio of 60.2% and a high current ratio. However, the accumulation of working capital due to persistently high DSO and DIO, as well as the increasing trend in short-term funding, particularly commercial paper, requires monitoring.

Theoretical Stock Price (Reference Value)

Sensitivity: ¥2,311–¥2,444 for ±1% in the cost of equity, and ¥2,343–¥2,398 for ±0.1 in ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated at a somewhat higher level.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market stock price or a recommendation of any specific investment action, nor does it forecast or guarantee the future stock price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---